Seagen
SGEN
#546
Rank
HK$335.94 B
Marketcap
HK$1,781
Share price
-0.07%
Change (1 day)
69.03%
Change (1 year)

Seagen (SGEN) - Net assets

Net assets on the balance sheet as of September 2023 : HK$19.85 Billion

According to Seagen 's latest financial reports the company has HK$19.85 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Seagen - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$HK$21.90 B-8.34%
2021-12-31$HK$23.90 B-11.61%
2020-12-31$HK$27.04 B85.05%
2019-12-31$HK$14.61 B46.48%
2018-12-31$HK$9.97 B88.45%
2017-12-31$HK$5.29 B7.66%
2016-12-31$HK$4.91 B-7.51%
2015-12-31$HK$5.31 B225.09%
2014-12-31$HK$1.63 B-8.38%
2013-12-31$HK$1.78 B1.83%
2012-12-31$HK$1.75 B3.13%
2011-12-31$HK$1.69 B35.23%
2010-12-31$HK$1.25 B-21.38%
2009-12-31$HK$1.59 B161.84%
2008-12-31$HK$0.61 B45.06%
2007-12-31$HK$0.42 B-38.66%
2006-12-31$HK$0.68 B17.3%
2005-12-31$HK$0.58 B-27.49%
2004-12-31$HK$0.80 B39.03%
2003-12-31$HK$0.58 B59.36%
2002-12-31$HK$0.36 B-23.02%
2001-12-31$HK$0.47 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ImmunoGen
IMGN
HK$4.37 B-77.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$141.73 B 613.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$4.65 B-76.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
HK$0.20 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$724.71 B 3,550.22%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$164.84 B 730.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
-HK$20.24 Billion-201.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B 629.29%๐Ÿ‡บ๐Ÿ‡ธ USA